Form 13-F position report

IRONWOOD PHARMACEUTICALS IN

Reported by Virtus Investment Advisers Inc

IRWD 0.75 06/15/24 CUSIP 46333XAF5 Manager CIK 0000019481

Reported 42,000 shares, unchanged from the prior quarter.

Reported value -4.9%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 0.03% This manager · Q1 2024
Shares 42,000 Quarter-end amount reported
Reported value $41,659 Fair value at quarter end
Consecutive quarters held 2 Through Q1 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-12-31 43785
2024-03-31 41659
2024-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

3 quarters
Quarterly reported position history for IRONWOOD PHARMACEUTICALS IN held by Virtus Investment Advisers Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2024 Reduced 0 -42,000 (-100.0%) 0 $0 2024-08-14
Q1 2024 Unchanged 42,000 0 (0.0%) 0.03% $41,659 2024-05-16
Q4 2023 New 42,000 +42,000 (0.0%) 0.03% $43,785 2024-02-15

Who else reported the position

26 managers reported IRONWOOD PHARMACEUTICALS IN for Q1 2024.

Managers reporting IRONWOOD PHARMACEUTICALS IN in Q1 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
CAPSTONE INVESTMENT ADVISORS LLC Unchanged 0 0 0.19% $51,538,438 15 qtrs
TENOR CAPITAL MANAGEMENT Co L P Added 37,375,000 +3,000,000 0.59% $37,177,224 15 qtrs
BRAIDWELL LP Reduced 20,000,000 -17,509,000 0.64% $19,937,500 3 qtrs
LAZARD ASSET MANAGEMENT LLC New 18,738,000 +18,738,000 0.02% $18,679,000 1 qtr
DeepCurrents Investment Group LLC New 18,500,000 +18,500,000 0.71% $18,383,266 1 qtr
Balyasny Asset Management LLC Reduced 18,000,000 -26,500,000 0.03% $17,894,986 2 qtrs
JPMorgan Chase & Co Added 10,804,000 +9,997,000 < 0.01% $10,709,681 15 qtrs
JEFFERIES FINANCIAL GROUP INC New 8,881,000 +8,881,000 0.08% $8,853,694 6 qtrs
BANK OF MONTREAL New 8,500,000 +8,500,000 < 0.01% $8,425,795 4 qtrs
Verition Fund Management LLC New 5,833,000 +5,833,000 0.04% $5,814,772 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2024
Filed
May 16, 2024
Filing type
13F-HR
Position type
NOTE 0.750% 6/1

Voting authority reported

Sole
42,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.